Timing It Right theory-based staged video education for patients on home enteral nutrition: A randomized controlled trial.

Nutr Clin PractJun 29, 2026 (epub)
Clinical ResearchGastroenterologyInternal Medicine (General)Preventive Medicine / Public Health

Yuanyuan Li, Meng Liu, Yang Yang et al.

✦ AI-curated · Sources linked

In 30 seconds

This randomized controlled trial evaluated the effectiveness of Timing It Right (TIR)-based staged video education for 100 patients on home enteral nutrition (HEN). The intervention group showed significant improvements in functional status, anxiety, and depression compared to the control group, with all P ≤ 0.001. No significant differences were observed in quality of life or readmission rates.

Key findings

  • The intervention group had significantly greater improvements in functional status (KPS) over time compared to the control group.
  • Anxiety (SAS) and depression (SDS) scores decreased significantly in the intervention group (P ≤ 0.001).
  • Patient satisfaction improved in the intervention group (PSQ-18, P < 0.05).

Why it matters

Effective patient education is crucial for managing home enteral nutrition, as it can significantly impact patients' functional status and mental health. This study highlights the importance of tailored educational interventions to meet evolving patient needs post-discharge.

Source

PubMed · PMID 42374803

Published in Nutr Clin Pract. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Gastroenterology

Clinical ResearchHematology

Ponatinib-Blinatumomab or Imatinib-Chemotherapy for Adult Ph-Positive ALL.

This multicenter, phase 3 randomized trial compared frontline ponatinib plus blinatumomab with imatinib plus chemotherapy in adults with Philadelphia-positive acute lymphoblastic leukemia.

N Engl J MedOct 15, 2026Read summary
Clinical ResearchHematology

Efficacy and safety of mitapivat in patients with sickle cell disease (RISE UP): a phase 3, double-blind, global, randomised, placebo-controlled trial.

RISE UP was a phase 3, double-blind, global, randomised, placebo-controlled trial conducted at 69 sites in 15 countries. It evaluated twice-daily mitapivat in patients older than 16 years with sickle cell disease…

LancetOct 24, 2026Read summary
Clinical ResearchRheumatology

Ianalumab for the Treatment of Patients with Sjögren's Disease.

Two 52-week, double-blind, randomized, placebo-controlled phase III trials evaluated monthly or less frequent ianalumab in patients with active Sjögren's disease.

N Engl J MedOct 22, 2026Read summary

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text
Create my personalized digestSee plans

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.